Related Experiment Video
Updated: May 26, 2026
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Targeting A-type K(+) channels in primary sensory neurons for bone cancer pain in a rat model
Kai-Zheng Duan1, Qian Xu, Xiao-Meng Zhang
1Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China School of Life Sciences, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200032, China.
Abstract:
Cancer pain is one of the most severe types of chronic pain, and the most common cancer pain is bone cancer pain. The treatment of bone cancer pain remains a clinical challenge. Here, we report firstly that A-type K(+) channels in dorsal root ganglion (DRG) are involved in the neuropathy of rat bone cancer pain and are a new target for diclofenac, a nonsteroidal anti-inflammatory drug that can be used for therapy for this distinct pain. There are dynamically functional changes of the A-type K(+) channels in DRG neurons during bone cancer pain. The A-type K(+) currents that mainly express in isolectin B4-positive small DRG neurons are increased on post-tumor day 14 (PTD 14), then faded but still remained at a higher level on PTD 21. Correspondingly, the expression levels of A-type K(+) channel Kv1.4, Kv3.4, and Kv4.3 showed time-dependent changes during bone cancer pain. Diclofenac enhances A-type K(+) currents in the DRG neurons and attenuates bone cancer pain in a dose-dependent manner. The analgesic effect of diclofenac can be reversed or prevented by A-type K(+) channel blocker 4-AP or pandinotoxin-Kα, also by siRNA targeted against rat Kv1.4 or Kv4.3. Repeated diclofenac administration decreased soft tissue swelling adjacent to the tumor and attenuated bone destruction. These results indicate that peripheral A-type K(+) channels were involved in the neuropathy of rat bone cancer pain. Targeting A-type K(+) channels in primary sensory neurons may provide a novel mechanism-based therapeutic strategy for bone cancer pain.
Insights
A-type K(+) channels in dorsal root ganglion (DRG) neurons are implicated in rat bone cancer pain. Diclofenac targets these channels, offering a new therapeutic strategy for managing severe bone cancer pain.
Area of Science:
- Neuroscience
- Pharmacology
- Oncology
Background:
- Bone cancer pain is a severe, challenging clinical issue.
- The underlying mechanisms of cancer pain neuropathy are not fully understood.
- A-type K(+) channels in dorsal root ganglion (DRG) neurons are investigated as a potential factor.
Purpose of the Study:
- To investigate the role of A-type K(+) channels in DRG neurons in rat bone cancer pain.
- To identify A-type K(+) channels as a novel therapeutic target for diclofenac in bone cancer pain.
- To explore the functional changes of A-type K(+) channels during bone cancer pain progression.
Main Methods:
- Electrophysiological recordings of A-type K(+) currents in DRG neurons.
- Analysis of A-type K(+) channel subunit expression (Kv1.4, Kv3.4, Kv4.3) over time.
- Pharmacological manipulation using diclofenac, A-type K(+) channel blockers (4-AP, pandinotoxin-Kα), and siRNA.
- Assessment of pain behavior and tumor-related tissue changes in rats.
Main Results:
- A-type K(+) currents in DRG neurons significantly increased during bone cancer pain development.
- Diclofenac demonstrated dose-dependent attenuation of bone cancer pain by enhancing A-type K(+) currents.
- The analgesic effects of diclofenac were reversed by A-type K(+) channel blockers and targeted siRNA, confirming the mechanism.
- Diclofenac treatment reduced tumor-associated swelling and bone destruction.
Conclusions:
- Peripheral A-type K(+) channels in DRG neurons are critically involved in the neuropathy of rat bone cancer pain.
- Targeting these A-type K(+) channels represents a novel, mechanism-based therapeutic strategy for bone cancer pain.
- Diclofenac's analgesic action is mediated through modulation of A-type K(+) channels in primary sensory neurons.
